The Pharmagellan Guide to Biotech Forecasting and Valuation
"Deserves a spot on the bookshelf of every biotech CFO."
- BRUCE BOOTH, Partner, Atlas Ventures
"A helpful and insightful resource for anyone who finds themselves staring at a blank Excel spreadsheet."
- ADAM FEUERSTEIN, Senior Columnist, TheStreet.com
"A fantastic plain-English guide ... unceasingly pragmatic. If you're trying to develop a reasonable view of the value of your program or company, this beautiful book breaks it down for you."
- MICHAEL GILMAN, Serial Biotech CEO (Stromedix, Padlock)
"Invaluable, rigorously detailed, and well-validated."
- JOHN SULLIVAN, Director of Equity Research, Leerink Partners
"Pragmatic, credible advice ... this is the book I wish I'd had when I started out in the industry."
- VIN MILANO, CEO, Idera Pharmaceuticals